
NIMTIAL-P DS SYP
November 6, 2024
MEROCAST SB 1.5
November 6, 2024
Description
Esomeprazole 40 mg powder for solution for injection/infusion is indicated in children and adolescents aged 1-18 years for: gastric antisecretory treatment when the oral route is not possible, such as: – gastroesophageal reflux disease (GERD) in patients with erosive reflux esophagitis and/or severe symptoms of reflux.
Additional information
Packing |
---|